Delaware Clinical and Translational Research ACCEL Program-BERD Core
Delaware Clinical and Translational Research ACCEL Program-BERD Core
批准号:
10437681
负责人:
Claudine Jurkovitz
金额:
$84.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-25 至 2023-07-31
关键词:
AddressAreaAwardBig DataBig Data to KnowledgeBioinformaticsBiomedical ResearchBiometryClinicalClinical InformaticsClinical ResearchCollaborationsCommunitiesComplexConsultationsDataData ScientistData SetDelawareE-learningEpidemiologistEpidemiologyFosteringFundingGenesGrantHealthHealth SciencesHealthcareHealthcare SystemsInformaticsInfrastructureInstitutesInstitutionInstitutional Review BoardsKnowledgeMedicalMedical InformaticsMethodsPartner in relationshipPediatric HospitalsPositioning AttributeProtocols documentationResearchResearch DesignResearch InstituteResearch PersonnelResearch Project GrantsResourcesScientistSeriesServicesSouth CarolinaTranslational ResearchUnited States National Institutes of HealthUniversitiesVisualizationbioinformatics resourcebiomedical informaticscomplex datacost effectivenessdata managementeducational atmosphereepidemiology studyexperiencegene discoverygene environment interactionhealth care deliveryinnovationlecturesmeetingsmemberpopulation healthprogramsresponsesuccess
中文摘要
Abstract-BERD
英文摘要
Abstract—BERD
The Biostatistics, Epidemiology and Research Design (BERD) KCA of the Delaware-CTR ACCEL has been success-
ful in meeting the original Specific Aims: providing consultations across ACCEL institutions, providing educational
forums, developing methods, and supporting the Big Data Pilot grants. BERD has skilled, experienced epidemiolo-
gists, biostatisticians, bioinformaticians, and biomedical informaticians forming a critical mass of scientists to sup-
port clinical and translational projects. This success has been fostered by close collaboration across the four current
ACCEL partner institutions: The University of Delaware (UD), the Nemours/Alfred I. DuPont Hospital for Children
(Nemours), Christiana Care Health System (CCHS), the Medical University of South Carolina (MUSC). We look
forward to welcoming Delaware State University (DSU) to BERD as part of this renewal. Each ACCEL institution has
organizational programs with expertise in epidemiology, biostatistics and bioinformatics, MUSC has an established
CTSA, the South Carolina Clinical and Translational Research Institute (SCTR). ACCEL in general and BERD in
particular have collaborated closely with SCTR. BERD also functions closely with the Value Institute (VI) at CCHS,
and the newly established Biomedical Research Infor-matics Center (BRIC) at Nemours. The VI is an innovative
research institute for studying healthcare delivery as well as translational research. BRIC is a team of bioinformati-
cians, data scientists, and developers formed in response to the expanding need for a bridge facility between research
and clinical informatics. In addition, UD and DSU both have considerable infrastructure and expertise in bioinfor-
matics. The scientists at the BRIC, SCTR, VI, UD and DSU add to the overall strength of ACCEL and BERD in further
developing infrastructure and the critical mass of investigators to support projects of importance concerning health
and healthcare in Delaware. BERD has also collaborated closely with the other ACCEL KCAs and a number of BERD
scientists are members of multiple KCAs, promoting component interconnectedness. The Specific Aims of BERD are
to: 1: Provide consultative services for clinical, translational and population health sciences at ACCEL institutions.
Consultative services include epidemiology, biostatistics, research design, data management, and bio- and medical
informatics. 2: Develop new, innovative, and quantitative methods in biostatistics, epidemiology, and bioinformatics.
3: Foster a learning environment through educational offerings in BERD scientists’ areas of expertise. 4: Leverage
the deep biomedical informatics and bioinformatics resources across the ACCEL institu-tions to support new and
extended research projects addressing critical healthcare needs in Delaware. We are well-positioned to provide such
support, building on the successful infrastructure established over the first AC-CEL award period, including develop-
ing external collaborations with multiple IDeA-funded centers, becoming an integral part of large-scale external data
networks such as PEDSnet and NIH Big Data to Knowledge (BD2K), and internally funding Big Data interdisciplin-
ary pilot grants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delaware Clinical and Translational Research ACCEL Program-BERD Core
-
批准号:10223329
-
项目类别:
-
资助金额:$84.9万
-
财政年份:2013
-
负责人:Claudine Jurkovitz
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: